TET2 deficiency increases the competitive advantage of hematopoietic stem and progenitor cells through upregulation of thrombopoietin receptor signaling

Related articles

1. Differential sensitivity to LINE 1-induced damage contributes to the expansion of Tet2-deficient HSCs upon chronic inflammatory stress

   This article has 20 authors:

   1. Anne Stolz
   2. Cheng Xuan
   3. Christelle Freitas
   4. Rabie Chelbi
   5. Hassan Ait-Ougouram
   6. David Fandrei
   7. Mengliang Ye
   8. Elisabeth Nelson
   9. Claire Maillard
   10. Mathieu Bohm
   11. Salomeh El-Choufani
   12. Audrey Porquet
   13. Weiwei Zhang
   14. Kahina Issoulaiene
   15. Christian Muchardt
   16. Elina Zueva
   17. Michele Goodhardt
   18. David Garrick
   19. Françoise Porteu
   20. Emilie Elvira-Matelot

2. MYD88 mutations in clonal hematopoiesis promote inflammation and hematopoietic stem cell expansion

   This article has 18 authors:

   1. Jennifer Yeung
   2. Sophia Y. Philbrook
   3. Emma Uible
   4. Lynn Lee
   5. Kwangmin Choi
   6. Puneet Agarwal
   7. Courtnee A. Clough
   8. Pravin Patel
   9. Kathryn A. Wikenheiser-Brokamp
   10. Kathleen Hueneman
   11. Hans Christian Reinhardt
   12. Tzyy-Jye Doong
   13. Arletta Lozanski
   14. Gerard Lozanski
   15. Tamanna Haque
   16. Erin Hertlein
   17. John C. Byrd
   18. Daniel T. Starczynowski

3. Multitargeted Reduction of Inflammation and Atherosclerosis in Tet2 -deficient CHIP via XPO1 Inhibition and Atf3 restoration

   This article has 17 authors:

   1. Nicole Prutsch
   2. Amélie Vromman
   3. Brittaney Leeper
   4. Mengyu Chen
   5. Julia Keating
   6. Shuning He
   7. Alla Berezovskaya
   8. Siyang Ren
   9. Mariana Janini Gomes
   10. Eduardo J. Folco
   11. Philipp J. Rauch
   12. Prafulla C. Gokhale
   13. Mark W. Zimmerman
   14. Donna S. Neuberg
   15. Brian J. Abraham
   16. Peter Libby
   17. A. Thomas Look